Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy — Stella

Home/Postoperative Hematoma/

View on ClinicalTrials.gov

Recruiting

Back to Postoperative Hematoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

UCSF Department of Plastic & Reconstructive Surgery, San Francisco, California

Key details

Phase

Safety & dosing

Sponsor

University of California, San Francisco

Enrollment target

~150 participants

Started

September 2023

Primary completion

May 2026

Age range

18 Years and older

Sex

Female only

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Last updated October 2025